200 related articles for article (PubMed ID: 27713137)
1. A long noncoding RNA positively regulates CD56 in human natural killer cells.
Zhang R; Ni F; Fu B; Wu Y; Sun R; Tian Z; Wei H
Oncotarget; 2016 Nov; 7(45):72546-72558. PubMed ID: 27713137
[TBL] [Abstract][Full Text] [Related]
2. CD56 regulates human NK cell cytotoxicity through Pyk2.
Gunesch JT; Dixon AL; Ebrahim TA; Berrien-Elliott MM; Tatineni S; Kumar T; Hegewisch-Solloa E; Fehniger TA; Mace EM
Elife; 2020 Jun; 9():. PubMed ID: 32510326
[TBL] [Abstract][Full Text] [Related]
3. Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56
Euchner J; Sprissler J; Cathomen T; Fürst D; Schrezenmeier H; Debatin KM; Schwarz K; Felgentreff K
Front Immunol; 2021; 12():640672. PubMed ID: 34017328
[TBL] [Abstract][Full Text] [Related]
4. Elevated exosome-transferrable lncRNA EPB41L4A-AS1 in CD56
Chai W; Wang X; Lu Z; Zhang S; Wang W; Wang H; Chen C; Yang W; Cheng H; Wang H; Feng J; Yang S; Li Q; Song W; Jin F; Zhang H; Su Y; Gui J
Clin Immunol; 2023 May; 250():109322. PubMed ID: 37024023
[TBL] [Abstract][Full Text] [Related]
5. Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells.
Mrózek E; Anderson P; Caligiuri MA
Blood; 1996 Apr; 87(7):2632-40. PubMed ID: 8639878
[TBL] [Abstract][Full Text] [Related]
6. CD56
Vujanovic L; Chuckran C; Lin Y; Ding F; Sander CA; Santos PM; Lohr J; Mashadi-Hossein A; Warren S; White A; Huang A; Kirkwood JM; Butterfield LH
Front Immunol; 2019; 10():14. PubMed ID: 30761123
[TBL] [Abstract][Full Text] [Related]
7. T-cell factor-1 expression during human natural killer cell development and in circulating CD56(+) bright natural killer cells.
Toor AA; Lund TC; Miller JS
Exp Hematol; 2001 Apr; 29(4):499-506. PubMed ID: 11301190
[TBL] [Abstract][Full Text] [Related]
8. Natural Killer and Natural Killer T Cells in Juvenile Systemic Lupus Erythematosus: Relation to Disease Activity and Progression.
Zahran AM; Abdel-Rahim MH; Elsayh KI; Hassanien MM; Mahran SA; Hetta HF
Arch Immunol Ther Exp (Warsz); 2019 Jun; 67(3):161-169. PubMed ID: 30944972
[TBL] [Abstract][Full Text] [Related]
9. The aryl hydrocarbon receptor modulates the function of human CD56
Moreno-Nieves UY; Mundy DC; Shin JH; Tam K; Sunwoo JB
Eur J Immunol; 2018 May; 48(5):771-776. PubMed ID: 29336030
[TBL] [Abstract][Full Text] [Related]
10. CD56+bright and CD56+dim natural killer cells in patients with chronic myelogenous leukemia progressively decrease in number, respond less to stimuli that recruit clonogenic natural killer cells, and exhibit decreased proliferation on a per cell basis.
Pierson BA; Miller JS
Blood; 1996 Sep; 88(6):2279-87. PubMed ID: 8822949
[TBL] [Abstract][Full Text] [Related]
11. Effect of Tyrosin Kinase Inhibitors on NK Cell and ILC3 Development and Function.
Damele L; Montaldo E; Moretta L; Vitale C; Mingari MC
Front Immunol; 2018; 9():2433. PubMed ID: 30405627
[TBL] [Abstract][Full Text] [Related]
12. The biology of human natural killer-cell subsets.
Cooper MA; Fehniger TA; Caligiuri MA
Trends Immunol; 2001 Nov; 22(11):633-40. PubMed ID: 11698225
[TBL] [Abstract][Full Text] [Related]
13. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset.
Cooper MA; Fehniger TA; Turner SC; Chen KS; Ghaheri BA; Ghayur T; Carson WE; Caligiuri MA
Blood; 2001 May; 97(10):3146-51. PubMed ID: 11342442
[TBL] [Abstract][Full Text] [Related]
14. Killer Ig-like receptor (KIR) genotype predicts the capacity of human KIR-positive CD56dim NK cells to respond to pathogen-associated signals.
Korbel DS; Norman PJ; Newman KC; Horowitz A; Gendzekhadze K; Parham P; Riley EM
J Immunol; 2009 May; 182(10):6426-34. PubMed ID: 19414796
[TBL] [Abstract][Full Text] [Related]
15. Immune Dysfunctions of CD56
Cao WJ; Zhang XC; Wan LY; Li QY; Mu XY; Guo AL; Zhou MJ; Shen LL; Zhang C; Fan X; Jiao YM; Xu RN; Zhou CB; Yuan JH; Wang SQ; Wang FS; Song JW
Front Immunol; 2021; 12():811091. PubMed ID: 35069597
[TBL] [Abstract][Full Text] [Related]
16. The dual-functional capability of cytokine-induced killer cells and application in tumor immunology.
Zhang Q; Liu XY; Zhang T; Zhang XF; Zhao L; Long F; Liu ZK; Wang EH
Hum Immunol; 2015 May; 76(5):385-91. PubMed ID: 25305457
[TBL] [Abstract][Full Text] [Related]
17. Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56(bright) subset.
Mace EM; Hsu AP; Monaco-Shawver L; Makedonas G; Rosen JB; Dropulic L; Cohen JI; Frenkel EP; Bagwell JC; Sullivan JL; Biron CA; Spalding C; Zerbe CS; Uzel G; Holland SM; Orange JS
Blood; 2013 Apr; 121(14):2669-77. PubMed ID: 23365458
[TBL] [Abstract][Full Text] [Related]
18. Interferon-γ production by tubulointerstitial human CD56
Law BMP; Wilkinson R; Wang X; Kildey K; Lindner M; Rist MJ; Beagley K; Healy H; Kassianos AJ
Kidney Int; 2017 Jul; 92(1):79-88. PubMed ID: 28396119
[TBL] [Abstract][Full Text] [Related]
19. Proteome analysis of distinct developmental stages of human natural killer (NK) cells.
Scheiter M; Lau U; van Ham M; Bulitta B; Gröbe L; Garritsen H; Klawonn F; König S; Jänsch L
Mol Cell Proteomics; 2013 May; 12(5):1099-114. PubMed ID: 23315794
[TBL] [Abstract][Full Text] [Related]
20. CD56 Expression Marks Human Group 2 Innate Lymphoid Cell Divergence from a Shared NK Cell and Group 3 Innate Lymphoid Cell Developmental Pathway.
Chen L; Youssef Y; Robinson C; Ernst GF; Carson MY; Young KA; Scoville SD; Zhang X; Harris R; Sekhri P; Mansour AG; Chan WK; Nalin AP; Mao HC; Hughes T; Mace EM; Pan Y; Rustagi N; Chatterjee SS; Gunaratne PH; Behbehani GK; Mundy-Bosse BL; Caligiuri MA; Freud AG
Immunity; 2018 Sep; 49(3):464-476.e4. PubMed ID: 30193847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
